Lack of persistence of influenza vaccine antibody titers in patients with heart failure

Caroline M. Albrecht, Nancy K Sweitzer, Maryl R. Johnson, Orly Vardeny

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Patients with heart failure (HF) have lower initial antibody responses to the influenza vaccine compared with healthy individuals. Whether antibody titers wane faster in this population remains unknown. Methods and Results We studied 62 HF patients (18 ischemic, 44 idiopathic) and 40 healthy control subjects (HC) during the 2006-2007 and 2007-2008 influenza seasons. Antibody titers were measured before and 2-4 weeks and 11-12 months after vaccination. Serum antibody production was measured by hemagglutination inhibition assay, and antibody titers to individual vaccine viral strains between the HF and HC groups were compared after the influenza season to measure persistence of antibody response. All participants demonstrated early antibody seroprotection (titers 40 hemmaglutination inhibition units to 1 strain). Although antibody titers waned over time in both groups, titers to A/H3N2 and A/H1N1 strains decreased more in HF than in HC participants (P =.004 and P =.04, respectively). Titers to the B-type strain decreased to below seroprotective levels in both groups. Conclusions Antibody titers to influenza A vaccine strains wane to below seroprotective levels in HF patients compared with HC, despite similar rates of initial seroprotection and seroconversion. These findings suggest that HF patients may remain at increased risk for influenza infection despite annual vaccination.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalJournal of Cardiac Failure
Volume20
Issue number2
DOIs
StatePublished - Feb 2014
Externally publishedYes

Fingerprint

Influenza Vaccines
Heart Failure
Antibodies
Healthy Volunteers
Human Influenza
Antibody Formation
Vaccination
Viral Vaccines
Hemagglutination
Control Groups
Infection
Serum
Population

Keywords

  • antibodies
  • Influenza
  • vaccine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lack of persistence of influenza vaccine antibody titers in patients with heart failure. / Albrecht, Caroline M.; Sweitzer, Nancy K; Johnson, Maryl R.; Vardeny, Orly.

In: Journal of Cardiac Failure, Vol. 20, No. 2, 02.2014, p. 105-109.

Research output: Contribution to journalArticle

Albrecht, Caroline M. ; Sweitzer, Nancy K ; Johnson, Maryl R. ; Vardeny, Orly. / Lack of persistence of influenza vaccine antibody titers in patients with heart failure. In: Journal of Cardiac Failure. 2014 ; Vol. 20, No. 2. pp. 105-109.
@article{7bf524a39428404ca34af58161361e2f,
title = "Lack of persistence of influenza vaccine antibody titers in patients with heart failure",
abstract = "Background Patients with heart failure (HF) have lower initial antibody responses to the influenza vaccine compared with healthy individuals. Whether antibody titers wane faster in this population remains unknown. Methods and Results We studied 62 HF patients (18 ischemic, 44 idiopathic) and 40 healthy control subjects (HC) during the 2006-2007 and 2007-2008 influenza seasons. Antibody titers were measured before and 2-4 weeks and 11-12 months after vaccination. Serum antibody production was measured by hemagglutination inhibition assay, and antibody titers to individual vaccine viral strains between the HF and HC groups were compared after the influenza season to measure persistence of antibody response. All participants demonstrated early antibody seroprotection (titers 40 hemmaglutination inhibition units to 1 strain). Although antibody titers waned over time in both groups, titers to A/H3N2 and A/H1N1 strains decreased more in HF than in HC participants (P =.004 and P =.04, respectively). Titers to the B-type strain decreased to below seroprotective levels in both groups. Conclusions Antibody titers to influenza A vaccine strains wane to below seroprotective levels in HF patients compared with HC, despite similar rates of initial seroprotection and seroconversion. These findings suggest that HF patients may remain at increased risk for influenza infection despite annual vaccination.",
keywords = "antibodies, Influenza, vaccine",
author = "Albrecht, {Caroline M.} and Sweitzer, {Nancy K} and Johnson, {Maryl R.} and Orly Vardeny",
year = "2014",
month = "2",
doi = "10.1016/j.cardfail.2013.12.008",
language = "English (US)",
volume = "20",
pages = "105--109",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Lack of persistence of influenza vaccine antibody titers in patients with heart failure

AU - Albrecht, Caroline M.

AU - Sweitzer, Nancy K

AU - Johnson, Maryl R.

AU - Vardeny, Orly

PY - 2014/2

Y1 - 2014/2

N2 - Background Patients with heart failure (HF) have lower initial antibody responses to the influenza vaccine compared with healthy individuals. Whether antibody titers wane faster in this population remains unknown. Methods and Results We studied 62 HF patients (18 ischemic, 44 idiopathic) and 40 healthy control subjects (HC) during the 2006-2007 and 2007-2008 influenza seasons. Antibody titers were measured before and 2-4 weeks and 11-12 months after vaccination. Serum antibody production was measured by hemagglutination inhibition assay, and antibody titers to individual vaccine viral strains between the HF and HC groups were compared after the influenza season to measure persistence of antibody response. All participants demonstrated early antibody seroprotection (titers 40 hemmaglutination inhibition units to 1 strain). Although antibody titers waned over time in both groups, titers to A/H3N2 and A/H1N1 strains decreased more in HF than in HC participants (P =.004 and P =.04, respectively). Titers to the B-type strain decreased to below seroprotective levels in both groups. Conclusions Antibody titers to influenza A vaccine strains wane to below seroprotective levels in HF patients compared with HC, despite similar rates of initial seroprotection and seroconversion. These findings suggest that HF patients may remain at increased risk for influenza infection despite annual vaccination.

AB - Background Patients with heart failure (HF) have lower initial antibody responses to the influenza vaccine compared with healthy individuals. Whether antibody titers wane faster in this population remains unknown. Methods and Results We studied 62 HF patients (18 ischemic, 44 idiopathic) and 40 healthy control subjects (HC) during the 2006-2007 and 2007-2008 influenza seasons. Antibody titers were measured before and 2-4 weeks and 11-12 months after vaccination. Serum antibody production was measured by hemagglutination inhibition assay, and antibody titers to individual vaccine viral strains between the HF and HC groups were compared after the influenza season to measure persistence of antibody response. All participants demonstrated early antibody seroprotection (titers 40 hemmaglutination inhibition units to 1 strain). Although antibody titers waned over time in both groups, titers to A/H3N2 and A/H1N1 strains decreased more in HF than in HC participants (P =.004 and P =.04, respectively). Titers to the B-type strain decreased to below seroprotective levels in both groups. Conclusions Antibody titers to influenza A vaccine strains wane to below seroprotective levels in HF patients compared with HC, despite similar rates of initial seroprotection and seroconversion. These findings suggest that HF patients may remain at increased risk for influenza infection despite annual vaccination.

KW - antibodies

KW - Influenza

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=84894591132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894591132&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2013.12.008

DO - 10.1016/j.cardfail.2013.12.008

M3 - Article

C2 - 24361852

AN - SCOPUS:84894591132

VL - 20

SP - 105

EP - 109

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 2

ER -